Evidence map›Paper›PMID 25553648›Full record

ArticleAging2014

Loss of Nfkb1 leads to early onset aging.

Giovanna M Bernal, Joshua S Wahlstrom, Clayton D Crawley, Kirk E Cahill, Peter Pytel, Hua Liang, Shijun Kang, Ralph R Weichselbaum, Bakhtiar Yamini

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Mice lacking NF-ĸB1 undergo premature ovarian aging.Reproductive biology and endocrinology : RB&E · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Senescent Heart-"Age Doth Wither Its Infinite Variety".International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Inflammation and aging: signaling pathways and intervention therapies.Signal transduction and targeted therapy · 2023
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Giovanna M BernalDepartment of Surgery, Section of Neurosurgery, University of Chicago, Chicago, IL 60637, USA.
Joshua S WahlstromDepartment of Surgery, Section of Neurosurgery, University of Chicago, Chicago, IL 60637, USA.
Clayton D CrawleyDepartment of Surgery, Section of Neurosurgery, University of Chicago, Chicago, IL 60637, USA.
Kirk E CahillDepartment of Surgery, Section of Neurosurgery, University of Chicago, Chicago, IL 60637, USA.
Peter PytelDepartment of Pathology, University of Chicago, Chicago, IL 60637, USA.
Hua LiangDepartment of Radiation and Cellular Oncology and the Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL 60637, USA.
Shijun KangDepartment of Surgery, Section of Neurosurgery, University of Chicago, Chicago, IL 60637, USA.
Ralph R WeichselbaumDepartment of Radiation and Cellular Oncology and the Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL 60637, USA.
Bakhtiar YaminiDepartment of Surgery, Section of Neurosurgery, University of Chicago, Chicago, IL 60637, USA.
University of Chicago · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
NF-kB1-p50 in the Response to DNA Alkylation DamageR01CA136937 · NCI · UNIVERSITY OF CHICAGO · PI YAMINI, BAKHTIAR · 2009 to 2019
$3.2M
NCATS NIH HHS UL1 TR000430NCI NIH HHS 1R01CA136937NCI NIH HHS R01 CA136937
6 · The paper itself

Abstract

NF-κB is a major regulator of age-dependent gene expression and the p50/NF-κB1 subunit is an integral modulator of NF-κB signaling. Here, we examined Nfkb1-/- mice to investigate the relationship between this subunit and aging. Although Nfkb1-/- mice appear similar to littermates at six months of age, by 12 months they have a higher incidence of several observable age-related phenotypes. In addition, aged Nfkb1-/- animals have increased kyphosis, decreased cortical bone, increased brain GFAP staining and a decrease in overall lifespan compared to Nfkb1+/+. In vitro, serially passaged primary Nfkb1-/- MEFs have more senescent cells than comparable Nfkb1+/+ MEFs. Also, Nfkb1-/- MEFs have greater amounts of phospho-H2AX foci and lower levels of spontaneous apoptosis than Nfkb1+/+, findings that are mirrored in the brains of Nfkb1-/- animals compared to Nfkb1+/+. Finally, in wildtype animals a substantial decrease in p50 DNA binding is seen in aged tissue compared to young. Together, these data show that loss of Nfkb1 leads to early animal aging that is associated with reduced apoptosis and increased cellular senescence. Moreover, loss of p50 DNA binding is a prominent feature of aged mice relative to young. These findings support the strong link between the NF-κB pathway and mammalian aging.

Indexed as

Aging, PrematureAge FactorsAgingAnimalsApoptosisBone and BonesBrainCells, CulturedCellular SenescenceDNAFibroblastsGenotypeGliosisHistonesInflammationKyphosisDNAgamma-H2AX protein, mouseHistonesNF-kappa B p50 SubunitNfkb1 protein, mouse

Identifiers

PMID25553648
PMCPMC4276787
OpenAlexW2130156384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.